V180

· National Institute of Allergy and Infectious Diseases

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for V180, covering 2016-04-04 to 2016-04-04. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005) [Phase 1]

See pricing